Patents by Inventor Richard Harland
Richard Harland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10261092Abstract: Compositions and methods for determining immunologically cross-reactive molecules comprising a cross-reactive antigenic determinant are provided, in particular for determining proteins comprising cross-reactive antigenic determinants, in particular for determining proteins that are cross-reactive based on serological screens using sequential immunological challenges to an animal, including determining cross-reactive H. parasuis proteins. Also provided are compositions, vaccines, and kits using the molecules for diagnostics and methods for preventing or treating a disease, disorder, condition, or symptoms thereof associated with infectious agents, in particular infectious microorganisms, in particular for preventing or treating a disease, disorder, condition, or symptom thereof associated with H. parasuis infection.Type: GrantFiled: April 27, 2015Date of Patent: April 16, 2019Assignee: Elanco Tiergesundheit AGInventors: Thomas Plocher, Manuel Campos, Richard Harland, Todd Johnson, Trent Harbison, Dan Keil
-
Publication number: 20150293118Abstract: Compositions and methods for determining immunologically cross-reactive molecules comprising a cross-reactive antigenic determinant are provided, in particular for determining proteins comprising cross-reactive antigenic determinants, in particular for determining proteins that are cross-reactive based on serological screens using sequential immunological challenges to an animal, including determining cross-reactive H. parasuis proteins. Also provided are compositions, vaccines, and kits using the molecules for diagnostics and methods for preventing or treating a disease, disorder, condition, or symptoms thereof associated with infectious agents, in particular infectious microorganisms, in particular for preventing or treating a disease, disorder, condition, or symptom thereof associated with H. parasuis infection.Type: ApplicationFiled: April 27, 2015Publication date: October 15, 2015Applicant: NOVARTIS TIERGESUNDHEIT AGInventors: Thomas Plocher, Manuel Campos, Richard Harland, Todd Johnson, Trent Harbison, Dan Keil
-
Patent number: 9046528Abstract: Compositions and methods for determining immunologically cross-reactive molecules comprising a cross-reactive antigenic determinant are provided, in particular for determining proteins comprising cross-reactive antigenic determinants, in particular for determining proteins that are cross-reactive based on serological screens using sequential immunological challenges to an animal, including determining cross-reactive H. parasuis proteins. Also provided are compositions, vaccines, and kits using the molecules for diagnostics and methods for preventing or treating a disease, disorder, condition, or symptoms thereof associated with infectious agents, in particular infectious microorganisms, in particular for preventing or treating a disease, disorder, condition, or symptom thereof associated with H. parasuis infection.Type: GrantFiled: March 20, 2009Date of Patent: June 2, 2015Assignee: Novartis Tiergesundheit AGInventors: Thomas Plocher, Manuel Campos, Richard Harland, Todd Johnson, Trent Harbison, Dan Keil
-
Patent number: 8637046Abstract: The disclosure relates generally to the treatment or prevention of disease in cattle. More particularly, the invention is directed to the production and use of modified bovine herpesvirus 1 (BHV-1) and their use in compositions and vaccines that protect cattle from BHV-1 infection while not suppressing the immunological response in the host. In one example, the invention is directed to the use of modified BHV-1, administered with additional immunogens, either through co-administration and/or through administration in combination vaccines, and the use of these vaccines for the protection of cattle from disease. In one example, use of the modified BHV-1 in the administered compositions facilitates an immune response to or against the additional immunogens.Type: GrantFiled: October 1, 2009Date of Patent: January 28, 2014Assignees: Cornell University, Novartis AGInventors: Nikolaus Osterrieder, Benedikt B. Kaufer, Gopinath Raju Seetharaman, Richard Harland, Lee David Albee, II, Mayur Navnitbhai Patel
-
Publication number: 20120318522Abstract: A modular containment cap for containing a subsea wellbore discharging hydrocarbons comprises a lower assembly including a spool body having an upper end, a lower end opposite the upper end, and a first throughbore extending from the upper end to the lower end. In addition the containment cap comprises an upper assembly including a spool piece having an upper end, a lower end opposite the upper end, a throughbore extending from the upper end to the lower end, and a first spool piece valve disposed in the throughbore. The first spool piece valve is configured to control the flow of fluids through the throughbore of the spool piece. The upper end of the spool body is releasably connected to the lower end of the spool piece, and the first throughbore of the spool body is coaxially aligned with and in fluid communication with the throughbore of the spool piece.Type: ApplicationFiled: May 10, 2012Publication date: December 20, 2012Applicant: BP Corporation North America Inc.Inventors: Robert Winfield Franklin, Richard Harland, Stuart Douglas Rettie, Roy Bryant Shilling, III
-
Publication number: 20120318521Abstract: A method for controlling hydrocarbons flowing from a subsea structure comprises lowering an adapter from the surface to a subsea structure. The adapter has a through bore extending between an upper connector having a first connector profile and a lower connector having a second connector profile that is different than the first connector profile. In addition, the method comprises coupling the lower connector of the adapter to the subsea structure. Further, the method comprises lowering a containment cap from the surface to the adapter. Still further, the method comprises coupling the containment cap to the upper connector of the adapter.Type: ApplicationFiled: May 10, 2012Publication date: December 20, 2012Applicant: BP CORPORATION NORTH AMERICA INC.Inventors: Robert Winfield Franklin, Richard Harland, Stuart Douglas Rettie, Roy Bryant Shilling, III
-
Publication number: 20120034262Abstract: The disclosure relates generally to the treatment or prevention of disease in cattle. More particularly, the invention is directed to the production and use of modified bovine herpesvirus 1 (BHV-1) and their use in compositions and vaccines that protect cattle from BHV-1 infection while not suppressing the immunological response in the host. In one example, the invention is directed to the use of modified BHV-1, administered with additional immunogens, either through co-administration and/or through administration in combination vaccines, and the use of these vaccines for the protection of cattle from disease. In one example, use of the modified BHV-1 in the administered compositions facilitates an immune response to or against the additional immunogens.Type: ApplicationFiled: October 1, 2009Publication date: February 9, 2012Applicants: NOVARTIS AG, CORNELL UNIVERSITYInventors: Nikolaus Osterrieder, Benedikt B. Kaufer, Gopinath Raju Seetharaman, Richard Harland, Lee David Albee, II, Mayur Navnitbhai Patel
-
Publication number: 20110014225Abstract: Compositions and methods for determining immunologically cross-reactive molecules comprising a cross-reactive antigenic determinant are provided, in particular for determining proteins comprising cross-reactive antigenic determinants, in particular for determining proteins that are cross-reactive based on serological screens using sequential immunological challenges to an animal, including determining cross-reactive H. parasuis proteins. Also provided are compositions, vaccines, and kits using the molecules for diagnostics and methods for preventing or treating a disease, disorder, condition, or symptoms thereof associated with infectious agents, in particular infectious microorganisms, in particular for preventing or treating a disease, disorder, condition, or symptom thereof associated with H. parasuis infection.Type: ApplicationFiled: March 20, 2009Publication date: January 20, 2011Applicant: NOVARTIS AGInventors: Thomas Plocher, Manuel Campos, Richard Harland, Todd Johnson, Trent Harbison, Dan Kiel
-
Patent number: 6571667Abstract: A latch device for a manual tong apparatus that incorporates a secondary catch mechanism is presented. Such a secondary catch would assist in maintaining the tong assembly in it's closed position during a reversing operation or at a time when load applied to the manual tong device in the gripping direction is very low. Additionally the secondary catch would also provide some additional protection by holding the tong assembly together in the event of a failure of certain tong components. The mechanism of the secondary catch is spring loaded and operates through two secondary up-down catch arms that are deactivated by swinging a handle in the direction that corresponds to the operator's natural motion to open the lug jaw.Type: GrantFiled: December 6, 2000Date of Patent: June 3, 2003Assignee: National-Oilwell, L.P.Inventors: Herman Paul Price, Richard Harland Miller, William Harold Macon
-
Publication number: 20030091579Abstract: Methods for raising uncastrated male animals for meat production are disclosed. The methods use compositions which include GnRH immunogens. The methods are useful for producing cuts of meat with enhanced organoleptic qualities.Type: ApplicationFiled: May 5, 1999Publication date: May 15, 2003Inventors: JACK G. MANNS, STEPHEN D. ACRES, RICHARD HARLAND
-
Publication number: 20020192219Abstract: DAN (Differential-screening-selected gene Aberrative in Neuroblastoma) and gremlin proteins and related nucleic acids are provided. Included are natural DAN and gremlin homologs from several species and proteins comprising a DAN or gremlin domain having specific activity, particularly the ability to antagonize a bone morphogenic protein. The proteins may be produced recombinantly from transformed host cells with the subject nucleic acids. Also provided are isolated hybridization probes and primers capable of specifically hybridizing with the disclosed genes, specific binding agents and methods of making and using the subject compositions.Type: ApplicationFiled: May 29, 2002Publication date: December 19, 2002Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Richard Harland, David Hsu
-
Patent number: 6432410Abstract: DAN (Differential-screening-selected gene Aberrative in Neuroblastoma) and gremlin proteins and related nucleic acids are provided. Included are natural DAN and gremlin homologs from several species and proteins comprising a DAN or gremlin domain having specific activity, particularly the ability to antagonize a bone morphogenic protein. The proteins may be produced recombinantly from transformed host cells with the subject nucleic acids. Also provided are isolated hybridization probes and primers capable of specifically hybridizing with the disclosed genes, specific binding agents and methods of making and using the subject compositions.Type: GrantFiled: March 13, 1998Date of Patent: August 13, 2002Assignee: The Regents of the University of CaliforniaInventors: Richard Harland, David Hsu
-
Publication number: 20020066339Abstract: A latch device for a manual tong apparatus that incorporates a secondary catch mechanism is presented. Such a secondary catch would assist in maintaining the tong assembly in it's closed position during a reversing operation or at a time when load applied to the manual tong device in the gripping direction is very low. Additionally the secondary catch would also provide some additional protection by holding the tong assembly together in the event of a failure of certain tong components. The mechanism of the secondary catch is spring loaded and operates through two secondary up-down catch arms that are deactivated by swinging a handle in the direction that corresponds to the operator's natural motion to open the lug jaw.Type: ApplicationFiled: December 6, 2000Publication date: June 6, 2002Inventors: Herman Paul Price, Richard Harland Miller, William Harold Macon
-
Publication number: 20010014330Abstract: A method is described for immunoneutralization of endogenous molecules in mammalian subjects, wherein an immunogen is administered via injection to the ear. The method is used to elicit an efficient and uniform immune response sufficient to block or suppress the activity of an endogenous hormone in a vaccinated subject, or to target a diseased cell for an immune response.Type: ApplicationFiled: February 5, 1998Publication date: August 16, 2001Inventors: RICHARD HARLAND, JOHN G. MANNS, STEPHEN D. ACRES